PROSTATE CANCER AND PROSTATIC DISEASES

PROSTATE CANCER AND PROSTATIC DISEASES Journal

publication venue for

Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy 2022
Copy number alterations are associated with metastatic-lethal progression in prostate cancer 2020
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS). 22:438-445. 2019

International Standard Serial Number (ISSN)

1365-7852

Electronic International Standard Serial Number (EISSN)

1476-5608